Capitol Gains: Navigating the Hill's Health Hurdles
E39

Capitol Gains: Navigating the Hill's Health Hurdles

Host: Rick Gannotta
Producer: Joe Woolworth
Guest: Andrew Barnhill, Director for Federal Policy at BioDelivery Sciences


Show Notes:

Introduction:

  • Welcome to the Healthcare Nation Podcast, hosted by Rick Gannotta, produced by Joe Woolworth.
  • Introduction to the guest, Andrew Barnhill, a returning policy expert.
  • Andrew's background: Director for Federal Policy at BioDelivery Sciences, advocate for value-based healthcare and patient reform, and instructor at NYU.

Episode Highlights:


Federal Health Policy Overview:

  • Current focus on PBM (Pharmacy Benefit Manager) reform and transparency in Congress.
  • Data privacy discussions and their implications for healthcare.
  • Rollout of the Inflation Reduction Act (IRA) and its impact on drug pricing.
  • Concerns about clinical trials and healthcare data involving China.

State-Level Health Policy Updates:

  • Maryland: Value-based purchasing pilot program for behavioral healthcare.
  • Oklahoma: Optional value-based arrangements for Medicaid providers.
  • Pennsylvania: Reauthorization of Rural Health Redesign Center Authority.
  • Minnesota: Analysis of total public healthcare spending for better financing.

Medicaid Developments:

  • Increased private sector interest in Medicaid solutions.
  • States experimenting with new ways to optimize care delivery.

Medicare Advantage Oversight:

  • Office of Inspector General (OIG) report on Medicare Advantage plans.
  • Focus on equitable access, financial oversight, fraud prevention, and data accuracy.

Impact of Upcoming Elections:

  • Potential shift in Senate control to Republicans and its implications for NIH and CDC.
  • Differences between a second Biden term and a potential Trump administration return.
  • Focus on public health agencies and drug pricing continuity under different administrations.

GLP-1 Drugs and Reimbursement:

  • Growing interest and debate over GLP-1 drugs for weight loss and diabetes.
  • State health plans making tough decisions about coverage.

AI in Healthcare:

  • Federal discussions on AI regulation, focusing initially on tech companies.
  • Healthcare sector developing policy principles for AI use.
  • Importance of high-quality data, patient-centered frameworks, and global alignment.

Data Privacy Legislation:

  • Progress on federal data privacy bill (APRA) gaining traction.
  • Importance of aligning privacy standards with healthcare data needs.

Healthcare Economics and Insurance:

  • Challenges in the insurance market, including cost pressures from innovative therapies.
  • Impact of the IRA on premiums and plan availability.

Venture Capital and Private Equity:

  • VC interest in gene therapy and innovative therapies despite IRA concerns.
  • Impact of policy on startup investments, particularly in med tech.

Key Takeaways:

  1. Pricing: Focus on drug pricing reforms and premium impacts.
  2. Privacy: Importance of passing federal privacy legislation with healthcare components.
  3. Public Health Programs: Continued support and potential changes in funding and leadership for public health agencies.

Conclusion:

  • Thank you to Andrew Barnhill for sharing his insights on health policy.
  • Encouragement to listeners to stay updated on healthcare policy developments.

Call to Action:

  • Subscribe to the Healthcare Nation Podcast for more expert discussions.
  • Follow us on social media and visit our website for the latest updates.

Episode Video

Creators and Guests

Rick Gannotta
Host
Rick Gannotta
Health sector executive clinician educator & researcher, RTs/links 🚫 not endorsements, TEDX; https://t.co/51mnBxpPqv @NYUWagner